Suvretta Capital Management’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$295K Hold
3,260
0.01% 89
2025
Q4
$293K Hold
3,260
0.01% 92
2025
Q3
$321K Hold
3,260
0.01% 92
2025
Q2
$297K Hold
3,260
0.01% 95
2025
Q1
$369K Hold
3,260
0.01% 96
2024
Q4
$344K Hold
3,260
0.01% 92
2024
Q3
$352K Hold
3,260
0.01% 95
2024
Q2
$354K Hold
3,260
0.01% 92
2024
Q1
$430K Buy
+3,260
New +$407K 0.02% 97
2020
Q1
Sell
-468,197
Closed -$68M 83
2019
Q4
$68M Sell
468,197
-177,500
-27% -$24.5M 1.55% 30
2019
Q3
$86.1M Sell
645,697
-259,426
-29% -$33.5M 2.23% 20
2019
Q2
$103M Buy
905,123
+543,799
+151% +$63.7M 2.19% 19
2019
Q1
$44.8M Buy
+361,324
New +$41.1M 1.3% 27

Other funds holding ZBH

Suvretta Capital Management's ZBH Position: Q1 2026 in Review

Suvretta Capital Management held its Zimmer Biomet (ZBH) position steady in Q1 2026 at 3,260 shares worth $295K. The position accounts for 0.01% of the portfolio, ranked #89.

Suvretta Capital Management first reported a position in ZBH in Q1 2019 and has held it in 13 quarters since. The position peaked at $103M in Q2 2019. 912 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.

  • Suvretta Capital Management held 3,260 shares of Zimmer Biomet worth $295K as of Q1 2026.
  • Suvretta Capital Management left its Zimmer Biomet share count unchanged in Q1 2026.
  • Zimmer Biomet made up 0.01% of Suvretta Capital Management's portfolio in Q1 2026, its #89 holding.
  • Suvretta Capital Management first reported a position in Zimmer Biomet in Q1 2019 and has held it in 13 quarters since.
  • Suvretta Capital Management's Zimmer Biomet position peaked at $103M in Q2 2019.
  • 912 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.

Based on Suvretta Capital Management's 13F filing for Q1 2026, filed 15 May 2026.